Evidence map›Paper›PMID 26578715›Full record

ArticleAmerican journal of physiology. Endocrinology and metabolism2016

Canonical Notch activation in osteocytes causes osteopetrosis.

Ernesto Canalis, David Bridgewater, Lauren Schilling, Stefano Zanotti

Abstract read
In one paragraph

Article in American journal of physiology. Endocrinology and metabolism, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. The Notch pathway regulates the bone gain induced by PTH anabolic signaling.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  9. Review
  10. The osteocyte as a signaling cell.Physiological reviews · 2022
    Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. The multifunctional role of Notch signaling in multiple myeloma.Journal of cancer metastasis and treatment · 2021
    Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Overexpression of Notch Signaling Induces Hyperosteogeny in Zebrafish.International journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ernesto CanalisDepartment of Orthopedic Surgery and the University of Connecticut Musculoskeletal Institute, Farmington, Connecticut; and Department of Medicine, University of Connecticut Health, Farmington, Connecticut canalis@uchc.edu.
David BridgewaterDepartment of Orthopedic Surgery and the University of Connecticut Musculoskeletal Institute, Farmington, Connecticut; and.
Lauren SchillingDepartment of Orthopedic Surgery and the University of Connecticut Musculoskeletal Institute, Farmington, Connecticut; and.
Stefano ZanottiDepartment of Orthopedic Surgery and the University of Connecticut Musculoskeletal Institute, Farmington, Connecticut; and Department of Medicine, University of Connecticut Health, Farmington, Connecticut.
UConn Health · US

Funding

Role of Notch Signaling in OsteocytesR01AR063049 · NIAMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI CANALIS, ERNESTO · 2013 to 2017
$1.8M
NIAMS NIH HHS AR-063049NIAMS NIH HHS R01 AR063049
6 · The paper itself

Abstract

Activation of Notch1 in cells of the osteoblastic lineage inhibits osteoblast differentiation/function and causes osteopenia, whereas its activation in osteocytes causes a distinct osteopetrotic phenotype. To explore mechanisms responsible, we established the contributions of canonical Notch signaling (Rbpjκ dependent) to osteocyte function. Transgenics expressing Cre recombinase under the control of the dentin matrix protein-1 (Dmp1) promoter were crossed with Rbpjκ conditional mice to generate Dmp1-Cre(+/-);Rbpjκ(Δ/Δ) mice. These mice did not have a skeletal phenotype, indicating that Rbpjκ is dispensable for osteocyte function. To study the Rbpjκ contribution to Notch activation, Rosa(Notch) mice, where a loxP-flanked STOP cassette is placed between the Rosa26 promoter and the NICD coding sequence, were crossed with Dmp1-Cre transgenic mice and studied in the context (Dmp1-Cre(+/-);Rosa(Notch);Rbpjκ(Δ/Δ)) or not (Dmp1-Cre(+/-);Rosa(Notch)) of Rbpjκ inactivation. Dmp1-Cre(+/-);Rosa(Notch) mice exhibited increased femoral trabecular bone volume and decreased osteoclasts and bone resorption. The phenotype was reversed in the context of the Rbpjκ inactivation, demonstrating that Notch canonical signaling was accountable for the phenotype. Notch activation downregulated Sost and Dkk1 and upregulated Axin2, Tnfrsf11b, and Tnfsf11 mRNA expression, and these effects were not observed in the context of the Rbpjκ inactivation. In conclusion, Notch activation in osteocytes suppresses bone resorption and increases bone volume by utilization of canonical signals that also result in the inhibition of Sost and Dkk1 and upregulation of Wnt signaling.

Indexed as

AnimalsBone RemodelingMiceMice, TransgenicOsteocytesOsteogenesisOsteopetrosisReceptors, NotchSignal TransductionReceptors, Notchbone remodelingNotchosteocytesRbpjκSost

Identifiers

PMID26578715
PMCPMC4719030
OpenAlexW2186609735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.